Women over the age of 18 diagnosed with initial, first time recurrent or second primary breast cancer BC within a year of diagnosis and not currently receiving chemotherapy or expecting to do so during the intervention. Additional medication is allowed, excluding anticholinergic medications which will be assessed for potential inclusion case by case. Participants need to be geographically located in Israel and able to complete assessments in Arabic or Hebrew and provide informed consent.
Interested potential participants will be screened for specific study exclusion criteria, which include but are not limited to being with in 6 months of myocardial infarction, or with a pacemaker.
If you are eligible and interested in participating, please contact us.